In the open-label study, DMD patients received Satellos’ oral drug for an additional 11 months, following an earlier 28-day trial.

BlockchainFX Launch approaches a key milestone as the BFX softcap needs just $96K. Explore the presale progress, listing ...

If someone told you 20 years ago that we’d be gaining new information through mini-computers in our pockets, you would ...

Learn how to use Apple’s built-in Foundation Model with Apfel. Run AI locally on your Mac with no API keys, no cloud fees and ...